Drug startup LambdaVision is shooting for the stars with an ambitious plan to develop the world’s first cure for genetic blindness — from space. LambdaVision was founded in 2009 with a mission to develop a protein-based artificial retina for patients with retinitis pigmentosa, a genetic cause of blindness, and macular degeneration, the leading cause of...
